BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 18698675)

  • 1. Inflammatory bowel disease: Moving toward a stem cell-based therapy.
    Lanzoni G; Roda G; Belluzzi A; Roda E; Bagnara GP
    World J Gastroenterol; 2008 Aug; 14(29):4616-26. PubMed ID: 18698675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cells as potential targeted therapy for inflammatory bowel disease.
    Gazouli M; Roubelakis MG; Theodoropoulos GE
    Inflamm Bowel Dis; 2014 May; 20(5):952-5. PubMed ID: 24572208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cells as potential therapeutic targets for inflammatory bowel disease.
    Singh UP; Singh NP; Singh B; Mishra MK; Nagarkatti M; Nagarkatti PS; Singh SR
    Front Biosci (Schol Ed); 2010 Jun; 2(3):993-1008. PubMed ID: 20515838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell therapy in inflammatory bowel disease: which, when and how?
    van Deen WK; Oikonomopoulos A; Hommes DW
    Curr Opin Gastroenterol; 2013 Jul; 29(4):384-90. PubMed ID: 23666365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Inflammatory Bowel Disease Using Stem Cell Therapy.
    Irhimeh MR; Cooney J
    Curr Stem Cell Res Ther; 2016; 11(1):72-7. PubMed ID: 26216128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Immune and Epithelial Stem Cells in Inflammatory Bowel Disease Therapy.
    Binienda A; Ziolkowska S; Hauge IH; Salaga M
    Curr Drug Targets; 2020; 21(14):1405-1416. PubMed ID: 32364073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal Stem Cell as a Potential Therapeutic for Inflammatory Bowel Disease- Myth or Reality?
    Adak S; Mukherjee S; Sen D
    Curr Stem Cell Res Ther; 2017; 12(8):644-657. PubMed ID: 28914206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell therapies for IBD: what works?
    Ricart E; Jauregui-Amezaga A; Ordás I; Pinó S; Ramírez AM; Panés J
    Curr Drug Targets; 2013 Nov; 14(12):1453-9. PubMed ID: 24160439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem Cell-Based Therapies for Inflammatory Bowel Disease.
    Zhang HM; Yuan S; Meng H; Hou XT; Li J; Xue JC; Li Y; Wang Q; Nan JX; Jin XJ; Zhang QG
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications Following Stem Cell Therapy in Inflammatory Bowel Disease.
    Wei H; Liu X; Ouyang C; Zhang J; Chen S; Lu F; Chen L
    Curr Stem Cell Res Ther; 2017; 12(6):471-475. PubMed ID: 28302045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell therapy for inflammatory bowel disease.
    Nagaishi K; Arimura Y; Fujimiya M
    J Gastroenterol; 2015 Mar; 50(3):280-6. PubMed ID: 25618180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy in inflammatory bowel disease: Novel and emerging treatments.
    Catalan-Serra I; Brenna Ø
    Hum Vaccin Immunother; 2018; 14(11):2597-2611. PubMed ID: 29624476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential methods for improving the efficacy of mesenchymal stem cells in the treatment of inflammatory bowel diseases.
    Zhang X; Wang S; Ding X; Guo J; Tian Z
    Scand J Immunol; 2020 Sep; 92(3):e12897. PubMed ID: 32443180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Features and management of very early onset inflammatory bowel disease].
    You JY
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 May; 20(5):341-345. PubMed ID: 29764567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases.
    Che Z; Ye Z; Zhang X; Lin B; Yang W; Liang Y; Zeng J
    Front Immunol; 2022; 13():952071. PubMed ID: 35990688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating cell therapy for inflammatory bowel disease.
    Okamoto R; Watanabe M
    Expert Opin Biol Ther; 2016 Aug; 16(8):1015-23. PubMed ID: 27113391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Treatment Options in Inflammatory Bowel Disease: Janus Kinases, Stem Cells, and More.
    Misselwitz B; Juillerat P; Sulz MC; Siegmund B; Brand S;
    Digestion; 2020; 101 Suppl 1():69-82. PubMed ID: 32570252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Mesenchymal Stem/Stromal Cell Therapy for Inflammatory Bowel Diseases: An Up-to-Date Systematic Review.
    Ko JZ; Johnson S; Dave M
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33440772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stromal cells and chronic inflammatory bowel disease.
    Algeri M; Conforti A; Pitisci A; Starc N; Tomao L; Bernardo ME; Locatelli F
    Immunol Lett; 2015 Dec; 168(2):191-200. PubMed ID: 26170204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.